GROUP R-PHARM IS SPECIALIZED
IN HIGH-TECH MEDICAL EQUIPMENT

MANUFACTURING
AND INNOVATIVE
PROJECTS
R-Pharm facilities are
functioning in accordance
with the latest GMP standards.
LEARN MORE
RESEARCH
AND DEVELOPMENT
R-Pharm has established
in-house scientific and research base.
LEARN MORE
BUSINESS ETHICS AND COMPLIANCE Quality of products and transparency, obedience to law and international standards LEARN MORE Career Pharm industry
is a specific segment of labor market.
LEARN MORE

COMPANY NEWS

Coronavir is one of the first medicine, both in Russia and globally, directly targeting the virus rather than merely addressing the...
read more...
September 17
Olokizumab is the first Russian original biologic for treatment of rheumatoid arthritis and also the first global direct inhibitor of...
read more...
September 14
The interim analysis of randomized Phase III clinical trial of Coronavir (favipiravir) has been published  in the peer-reviewed scientific...
read more...
August 10
R-Pharm Group announces positive results of CREDO 2, a pivotal global (1648 patients in 18 countries) Phase III clinical study of IL-6...
read more...
July 2
R-Pharm Holding, LLC (Headquarters: Moscow, Russia; Chairman: Alexey Repik, hereinafter R-Pharm) and Canon Medical Systems Corporation...
read more...
June 22

Partnership

The strategy of a successful partnership, mutually beneficial cooperation, commitment and performance of goals